递归制药

关于 Recursion Pharmaceuticals

Recursion 制药, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion 运营 system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was 成立 by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is 总部位于 in Salt Lake City, UT.

成立时间

2013

首席执行官

Dr. Najat Khan, PhD

员工人数

600

总部地址

Salt Lake City, Utah, United States of America

财年结束日

12-31

官方网站

recursion.com

公司概况

交易所

US

股票代码

RXRX

市值排名

#2649

上市日期

2021-04-16

市值

2.07B

流通市值

2.01B

总股数

597.81M

流通股数

580.95M

行业与主题板块

浏览全部行业与主题板块